114 related articles for article (PubMed ID: 35742860)
1. Combining Recombinase-Mediated Cassette Exchange Strategy with Quantitative Proteomic and Phosphoproteomic Analyses to Inspect Intracellular Functions of the Tumor Suppressor Galectin-4 in Colorectal Cancer Cells.
Michalak M; Golde V; Helm D; Kaltner H; Gebert J; Kopitz J
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742860
[TBL] [Abstract][Full Text] [Related]
2. Integrated proteomic and phosphoproteomic analysis for characterization of colorectal cancer.
Zhu H; Li Y; Guo J; Feng S; Ge H; Gu C; Wang M; Nie R; Li N; Wang Y; Wang H; Zhong J; Qian X; He G
J Proteomics; 2023 Mar; 274():104808. PubMed ID: 36596410
[TBL] [Abstract][Full Text] [Related]
3. Detection of malignancy-associated phosphoproteome changes in human colorectal cancer induced by cell surface binding of growth-inhibitory galectin-4.
Michalak M; Warnken U; Schnölzer M; Gabius HJ; Kopitz J
IUBMB Life; 2019 Mar; 71(3):364-375. PubMed ID: 30550624
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116.
Lee J; Ballikaya S; Schönig K; Ball CR; Glimm H; Kopitz J; Gebert J
PLoS One; 2013; 8(2):e57074. PubMed ID: 23468914
[TBL] [Abstract][Full Text] [Related]
5. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
6. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J
Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466
[TBL] [Abstract][Full Text] [Related]
7. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
[TBL] [Abstract][Full Text] [Related]
8. RUFY3 interaction with FOXK1 promotes invasion and metastasis in colorectal cancer.
Xie R; Wang J; Liu X; Wu L; Zhang H; Tang W; Li Y; Xiang L; Peng Y; Huang X; Bai Y; Liu G; Li A; Wang Y; Chen Y; Ren Y; Li G; Gong W; Liu S; Wang J
Sci Rep; 2017 Jun; 7(1):3709. PubMed ID: 28623323
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells.
Zhao XY; Chen TT; Xia L; Guo M; Xu Y; Yue F; Jiang Y; Chen GQ; Zhao KW
Carcinogenesis; 2010 Aug; 31(8):1367-75. PubMed ID: 20525878
[TBL] [Abstract][Full Text] [Related]
10. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer.
Li XN; Wang ZJ; Ye CX; Zhao BC; Li ZL; Yang Y
J Exp Clin Cancer Res; 2018 Dec; 37(1):325. PubMed ID: 30591054
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of circAPLP2 Inhibits Progression of Colorectal Cancer by Regulating miR-485-5p/FOXK1 Axis.
Liu J; Zhang J; Wang Z; Xi J; Bai L; Zhang Y
Cancer Biother Radiopharm; 2021 Nov; 36(9):737-752. PubMed ID: 32343603
[No Abstract] [Full Text] [Related]
12. Promoter SNPs rs116896264 and rs73933062 form a distinct haplotype and are associated with galectin-4 overexpression in colorectal cancer.
Helwa R; Ramadan M; Abdel-Wahab AH; Knappskog S; Bauer AS
Mutagenesis; 2016 Jul; 31(4):401-8. PubMed ID: 26681582
[TBL] [Abstract][Full Text] [Related]
13. De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach.
Ballikaya S; Lee J; Warnken U; Schnölzer M; Gebert J; Kopitz J
Mol Cell Proteomics; 2014 Dec; 13(12):3446-56. PubMed ID: 25225355
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
[TBL] [Abstract][Full Text] [Related]
15. Expression of Zinc Finger and BTB Domain-containing 7A in Colorectal Carcinoma.
Joo JW; Kim HS; Do SI; Sung JY
Anticancer Res; 2018 May; 38(5):2787-2792. PubMed ID: 29715100
[TBL] [Abstract][Full Text] [Related]
16. Analyzing epigenetic control of galectin expression indicates silencing of galectin-12 by promoter methylation in colorectal cancer.
Katzenmaier EM; Kloor M; Gabius HJ; Gebert J; Kopitz J
IUBMB Life; 2017 Dec; 69(12):962-970. PubMed ID: 29098769
[TBL] [Abstract][Full Text] [Related]
17. Quantitative phosphoproteomic analysis reveals system-wide signaling pathways regulated by site-specific phosphorylation of Keratin-8 in skin squamous cell carcinoma derived cell line.
Tiwari R; Sahu I; Soni BL; Sathe GJ; Datta KK; Thapa P; Sinha S; Vadivel CK; Dhaka B; Gowda H; Vaidya MM
Proteomics; 2017 Apr; 17(7):. PubMed ID: 28176443
[TBL] [Abstract][Full Text] [Related]
18. The FOXK1-CCDC43 Axis Promotes the Invasion and Metastasis of Colorectal Cancer Cells.
Wang J; Liu G; Liu M; Xiang L; Xiao Y; Zhu H; Wu X; Peng Y; Zhang W; Jiang P; Li A; Nan Q; Chen Y; Chen C; Cheng T; Liu S; Wang J
Cell Physiol Biochem; 2018; 51(6):2547-2563. PubMed ID: 30562730
[TBL] [Abstract][Full Text] [Related]
19. Galectin-4 functions as a tumor suppressor of human colorectal cancer.
Satelli A; Rao PS; Thirumala S; Rao US
Int J Cancer; 2011 Aug; 129(4):799-809. PubMed ID: 21064109
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer.
Kim SW; Park KC; Jeon SM; Ohn TB; Kim TI; Kim WH; Cheon JH
Cell Oncol (Dordr); 2013 Apr; 36(2):169-78. PubMed ID: 23378274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
